Toxic shock syndrome in the United States: surveillance update, 1979 1996.
about
Case report: Molluscum contagiosum. Toxic shock syndrome following cantharidin treatmentIntense, flu-like symptoms in women using menstrual devices: always think of staphylococcal Toxic Shock Syndrome.Staphylococcal toxic shock syndrome 2000-2006: epidemiology, clinical features, and molecular characteristics.Prevalence of toxic shock syndrome toxin 1-producing Staphylococcus aureus and the presence of antibodies to this superantigen in menstruating womenGlobal repression of exotoxin synthesis by staphylococcal superantigens.Staphylococcal toxic shock syndrome. Suspicion and prevention are keys to control.Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management.Aches and pains with a shocking rashNew insights into the prevention of staphylococcal infections and toxic shock syndrome.A fatal case of staphylococcal toxic shock syndrome.Impact of Advertising on Tampon Wear-time PracticesPrevalence of toxic shock syndrome toxin 1 (TSST-1)-producing strains of Staphylococcus aureus and antibody to TSST-1 among healthy Japanese women.Evaluation of surveillance methods for staphylococcal toxic shock syndrome.Bacterial Toxins-Staphylococcal Enterotoxin B.Recurrent Streptococcus agalactiae Toxic Shock Syndrome Triggered by a Tumor Necrosis Factor-α Inhibitor.Mesenchymal stromal (stem) cells suppress pro-inflammatory cytokine production but fail to improve survival in experimental staphylococcal toxic shock syndrome.Clarithromycin Plus Intravenous Immunoglobulin Therapy Can Reduce the Relapse Rate of Kawasaki Disease: A Phase 2, Open-Label, Randomized Control StudyEpidemiology and hospital readmission associated with complications of Staphylococcus aureus bacteremia in pediatrics over a 25-year period.Examining the safety of menstrual cups among rural primary school girls in western Kenya: observational studies nested in a randomised controlled feasibility study.Prevalence, comorbidities and mortality of toxic shock syndrome in United States children and adults.Treatment of Staphylococcus aureus Infections.Toxic shock syndrome caused by suture abscess with methicillin-resistant Staphylococcus aureus (MRSA) with late onset after Caesarean section.Rapid and Rigorous IL-17A Production by a Distinct Subpopulation of Effector Memory T Lymphocytes Constitutes a Novel Mechanism of Toxic Shock Syndrome Immunopathology.Understanding toxic shock syndrome.Antimicrobial activity and chemical composition of endemic Centaurea cariensis subsp. niveo-tomentosa.Toxic shock syndrome surveillance in UK children.Chemical composition, antimicrobial and antioxidant activities of Centaurea ensiformis Hub.-Mor. (Asteraceae), a species endemic to Mugla (Turkey).Clinical and Molecular Epidemiology of Staphylococcal Toxic Shock Syndrome in the United Kingdom.Polymyxin-B immobilized column-direct hemoperfusion for adolescent toxic shock syndrome.Sexual dimorphism in superantigen shock involves elevated TNF-alpha and TNF-alpha induced hepatic apoptosis.Manipulation of Innate and Adaptive Immunity by Staphylococcal Superantigens.Sexual dimorphism in bacterial infections.Complex ecological interactions of Staphylococcus aureus in tampons during menstruation.
P2860
Q24645293-27EF5FAF-311A-4B39-B99E-F94CCFD861DFQ33738437-13D738ED-2209-4956-A490-073D36B86451Q34000838-65BF2B0C-3E43-40DC-B892-A1E4A4D17268Q34042333-788A8740-42F4-42CA-97F4-5D843D9ED84DQ34099174-008D4220-DBE8-43BF-A99F-3A29ADEB3B52Q34417435-F62470F2-C37D-4B75-A1A5-C5A747312E46Q34478074-2E61CC68-47A8-47D9-A457-16A7F42A464CQ34775531-F7E42D4C-C9B9-4D0A-93D1-4DD5C1F47DAEQ35008802-5F3DDB15-4263-431B-A499-5FFE0B57FC65Q35929658-962141A0-7DE7-4E52-A564-4252CB48FB91Q36331708-F20CEB71-E66C-4216-8684-6AF46CE8FE17Q36845339-E611F065-84A1-4326-B80A-BA336D6D0D5DQ37203725-A4125BE9-F991-4C83-8EB1-B038D883B289Q37378451-EC605D6E-218F-43FD-B5F7-888A23A6923CQ37478942-6A20EDE0-EC44-4DCE-A57C-B39722EE9B79Q37501623-9A0CC064-ACCF-44C1-8EAA-349F7357CEEBQ38374445-75FC790A-6305-45D3-98A3-ECBE0C287F8FQ38658231-FE7C378F-FA90-4A17-B9F9-4E29D41A9544Q39113076-97FCBAD5-C20F-42FB-A73D-F7182BB73123Q40047791-C08056D6-A76A-44DD-BC86-16FF1BBB874AQ40049973-74025D88-3CB2-4A9C-9350-B29257FC8337Q40101072-F5C13E4B-0ED6-40FE-B000-836563C81C19Q40324830-20ED5E87-D8A2-408E-B102-FE4001D49FBCQ41234193-E8FA3E61-7F75-4E45-892C-287522EE6031Q42167011-744BB291-C4E3-4CFD-BE87-508CCC3D0409Q42216913-23111EE5-3B8C-4987-BEE2-6A7823AB12C7Q46144647-93712810-97B8-475D-B85E-11E98624FF82Q47723974-3E26894D-8C73-4812-B847-8C628725393FQ51349847-B069B723-3919-4D7E-9FF0-2CEDC8FD0732Q51749912-AF54D1F7-F269-4E5F-9390-461BDA58BC58Q54779554-BD6C7BA2-EC1A-499E-9604-5DC5F2520D45Q55431367-0C51057E-3BA0-454D-8E07-305BCDCBACDBQ55517606-EE3C95A7-7152-48A7-B0A5-879E51CBEE7D
P2860
Toxic shock syndrome in the United States: surveillance update, 1979 1996.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh
1999年學術文章
@zh-hant
name
Toxic shock syndrome in the United States: surveillance update, 1979 1996.
@en
Toxic shock syndrome in the United States: surveillance update, 1979 1996.
@nl
type
label
Toxic shock syndrome in the United States: surveillance update, 1979 1996.
@en
Toxic shock syndrome in the United States: surveillance update, 1979 1996.
@nl
prefLabel
Toxic shock syndrome in the United States: surveillance update, 1979 1996.
@en
Toxic shock syndrome in the United States: surveillance update, 1979 1996.
@nl
P2093
P356
P1476
Toxic shock syndrome in the United States: surveillance update, 1979 1996.
@en
P2093
P304
P356
10.3201/EID0506.990611
P577
1999-11-01T00:00:00Z